Abeona Therapeutics, Inc. (ABEO)
5.99
+0.01
(+0.17%)
USD |
NASDAQ |
Sep 02, 10:20
Abeona Therapeutics Research and Development Expense (Annual) : 24.26M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 24.26M |
| December 31, 2024 | 34.36M |
| December 31, 2023 | 31.09M |
| December 31, 2022 | 28.96M |
| December 31, 2021 | 34.32M |
| December 31, 2020 | 30.14M |
| December 31, 2019 | 48.57M |
| December 31, 2018 | 38.70M |
| December 31, 2017 | 16.99M |
| December 31, 2016 | 10.66M |
| December 31, 2015 | 4.715M |
| December 31, 2014 | 0.333M |
| December 31, 2013 | 0.884M |
| Date | Value |
|---|---|
| December 31, 2012 | 2.01M |
| December 31, 2011 | 4.20M |
| December 31, 2010 | 3.349M |
| December 31, 2009 | 2.657M |
| December 31, 2008 | 12.61M |
| December 31, 2007 | 2.602M |
| December 31, 2006 | 2.053M |
| December 31, 2005 | 2.783M |
| December 31, 2004 | 2.335M |
| December 31, 2003 | 6.096M |
| December 31, 2002 | 7.024M |
| December 31, 2001 | 4.174M |
| December 31, 2000 | 4.007M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Forum Markets, Inc. | -- |
| Corcept Therapeutics, Inc. | 254.91M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Anika Therapeutics, Inc. | 25.77M |